TRK-inhibitor control of an NTRK-rearranged spindle cell tumor with malignant transformation in an adolescent

Pediatr Blood Cancer. 2023 May 2:e30379. doi: 10.1002/pbc.30379. Online ahead of print.

Naoko Higuchi¹, Yuko Honda¹, Yuhki Koga², Hiroshi Asai^{1

2}, Hiroaki Ono², Wakako Kato^{1

2}, Kentaro Nakashima^{1

2}, Esther De La Cuesta³, Toshiaki Tsujino⁴, Hidetaka Yamamoto⁵, Koichi Kusuhara¹, Masanori Hisaoka⁶, Shouichi Ohga²

¹ Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
² Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
³ Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA.
⁴ Bayer Yakuhin, Ltd., Osaka, Japan.
⁵ Department of Anatomic Pathology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka, Japan.
⁶ Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

No abstract available

Publication types